Literature DB >> 2803236

Further evidence for a two-step model of glucose-transport regulation. Inositol phosphate-oligosaccharides regulate glucose-carrier activity.

B Obermaier-Kusser1, C Mühlbacher, J Mushack, E Seffer, B Ermel, F Machicao, F Schmidt, H U Häring.   

Abstract

The insulin effect on glucose uptake is not sufficiently explained by a simple glucose-carrier translocation model. Recent studies rather suggest a two-step model of carrier translocation and carrier activation. We used several pharmacological tools to characterize the proposed model further. We found that inositol phosphate (IP)-oligosaccharides isolated from the drug Actovegin, as well as the alkaloid vinblastine, show a partial insulin-like effect on glucose-transport activity of fat-cells (3-O-methylglucose uptake, expressed as % of equilibrium value per 4 s: basal 5.8%, insulin 59%, IP-oligosaccharides 30%, vinblastine 29%) without inducing carrier translocation. On the other hand, two newly developed anti-diabetic compounds (alpha-activated carbonic acids, BM 130795 and BM 13907) induced carrier translocation to the same extent as insulin and phorbol esters [cytochalasin-B-binding sites in plasma membranes: basal 5 pmol/mg of protein, insulin 13 pmol/mg of protein, TPA (12-O-tetradecanoylphorbol 13-acetate) 11.8 pmol/mg of protein, BM 130795 10.8 pmol/mg of protein], but produce also only 40-50% of the insulin effect on glucose-transport activity (basal 5.8%, insulin 59%, TPA 23%, BM 130795 35%). Almost the full insulin effect was mimicked by a combination of phorbol esters and IP-oligosaccharides (basal 7%, insulin 50%, IP-oligosaccharides 30%, TPA 23%, IP-oligosaccharides + TPA 45%). None of these substances stimulated insulin-receptor kinase in vitro or in vivo, suggesting a post-kinase site of action. The data confirm the following aspects of the proposed model: (1) carrier translocation and carrier activation are two independently regulated processes; (2) the full insulin effect is mimicked only by a simultaneous stimulation of carrier translocation and intrinsic carrier activity, suggesting that insulin acts through a synergism of both mechanisms; (3) IP-oligosaccharides might be involved in the transmission of a stimulatory signal on carrier activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803236      PMCID: PMC1138887          DOI: 10.1042/bj2610699

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  An Mr 180,000 protein is an endogenous substrate for the insulin-receptor-associated tyrosine kinase in human placenta.

Authors:  F Machicao; H Häring; M F White; J M Carrascosa; B Obermaier; O H Wieland
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

2.  Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

Authors:  G A McPherson
Journal:  J Pharmacol Methods       Date:  1985-11

Review 3.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

4.  Mechanism of insulin action on glucose transport in the isolated rat adipose cell. Enhancement of the number of functional transport systems.

Authors:  L J Wardzala; S W Cushman; L B Salans
Journal:  J Biol Chem       Date:  1978-11-25       Impact factor: 5.157

5.  Reconstitution of D-glucose transport activity from cytoplasmic membranes. Evidence against recruitment of cytoplasmic membrane transporters into the plasma membrane as the sole action of insulin.

Authors:  C Carter-Su; M P Czech
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

6.  Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane.

Authors:  S W Cushman; L J Wardzala
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

7.  Insulin activates phospholipase C in fat cells: similarity with the activation of pyruvate dehydrogenase.

Authors:  B Koepfer-Hobelsberger; O H Wieland
Journal:  Mol Cell Endocrinol       Date:  1984-06       Impact factor: 4.102

8.  Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells.

Authors:  M F White; R Maron; C R Kahn
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

9.  Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.

Authors:  K Suzuki; T Kono
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Preparation and characterization of a plasma membrane fraction from isolated fat cells.

Authors:  D W McKeel; L Jarett
Journal:  J Cell Biol       Date:  1970-02       Impact factor: 10.539

View more
  16 in total

1.  The translocation of the glucose transporter sub-types GLUT1 and GLUT4 in isolated fat cells is differently regulated by phorbol esters.

Authors:  B Vogt; J Mushack; E Seffer; H U Häring
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

Review 2.  The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance.

Authors:  H U Häring
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

Review 3.  Control of cardiomyocyte gene expression as drug target.

Authors:  H Rupp; M Benkel; B Maisch
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

4.  Phorbol ester only partially mimics the effects of insulin on glucose transport and glucose-transporter distribution in 3T3-L1 adipocytes.

Authors:  E M Gibbs; D M Calderhead; G D Holman; G W Gould
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  Mannose, glucosamine and inositol monophosphate inhibit the effects of insulin on lipogenesis. Further evidence for a role for inositol phosphate-oligosaccharides in insulin action.

Authors:  F Machicao; J Mushack; E Seffer; B Ermel; H U Häring
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

6.  Differential influence of fasting and BM13.907 treatment on growth and phenotype of pressure overloaded rat heart.

Authors:  H Rupp; V Elimban; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Insulin-induced translocation of GLUT 4 in skeletal muscle of insulin-resistant Zucker rats.

Authors:  P Galante; E Maerker; R Scholz; K Rett; L Herberg; L Mosthaf; H U Häring
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

8.  Subcellular distribution of GLUT 4 in the skeletal muscle of lean type 2 (non-insulin-dependent) diabetic patients in the basal state.

Authors:  B Vogt; C Mühlbacher; J Carrascosa; B Obermaier-Kusser; E Seffer; J Mushack; D Pongratz; H U Häring
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

Review 9.  Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle.

Authors:  H U Häring; H Mehnert
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

10.  Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.

Authors:  Dan Ziegler; Lusine Movsesyan; Boris Mankovsky; Irina Gurieva; Zhangentkhan Abylaiuly; Igor Strokov
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.